7 Hills Pharma Inc.

About 7 Hills Pharma Inc.

7 Hills Pharma is a clinical-stage drug development company focused on advancing first-in-class integrin-targeted agonists to safely enhance the effectiveness of immunotherapies for cancer and stem cell transplantation. Their mission is to build a world where safe and effective cancer treatments are accessible to all.

Products & Services

Alintegimod (formerly 7HP349):A first-in-class dual LFA-1 and VLA-4 agonist used in combination with immune checkpoint inhibitors to overcome resistance to anti-PD-1 drugs in solid tumors. Currently in Phase Ib/IIa clinical trial.

7HP935:A small molecule in IND-enabling studies aimed at improving the effectiveness of CD34+ cell-based therapies for acute leukemias and genetic disorders of the bone marrow.

Specialties

Integrin-targeted agonists Cancer immunotherapy Stem cell transplantation Hematology and oncology drug development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 4700000 MR: - FA: $4.7MM FAN: 4700000	D: 2024-06-03 FD: 2024-06-03	1 investors
2	RT: Grant T: - FT: Grant	A: 13500000 MR: - FA: 13.5MM FAN: 13500000	D: 2023-05-22 FD: 2023-05-22	1 investors

Grant Latest

2024-06-03

$4.7M

1 investor (Pro only)

Grant 2023-05-22

$13.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

U

Upendra Marathi

Co-founder

LinkedIn (Pro only)

L

Lionel Lewis

Chief Medical Officer

LinkedIn (Pro only)

R

Rob Bent

Chief Financial Officer

LinkedIn (Pro only)

W

William Schary

VP Clinical and Regulatory Affairs

S

Siddhartha De

VP Research & Development

N

Nicole Gallegos

Senior Director of Clinical and Regulatory Affairs

View 15 more team members with Pro

Unlock Full Team Directory

Recent News